Dendrisomes: Vesicular structures derived from a cationic lipidic dendron

被引:19
作者
Al-Jamal, KT [1 ]
Sakthivel, T [1 ]
Florence, AT [1 ]
机构
[1] Univ London, Sch Pharm, Ctr Drug Delivery Res, London WC1N 1AX, England
关键词
dendrimer; dendron; self-assembly; dendrisome; drug carrier;
D O I
10.1002/jps.20161
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The behavior of a novel synthetic lipidic cationic lysine-based dendron (partial dendrimer) in aqueous media and its ability, with and without cholesterol, to self-assemble into higher order structures was studied to gain an understanding of these structures as potential drug carriers. The dendron was prepared by solid-phase peptide synthesis. A reverse-phase evaporation (REV) technique was used to prepare cationic vesicular aggregates of the dendron with different molar ratios of cholesterol. The size and zeta potential of these supramolecular aggregates or "dendrisomes" was determined by photon correlation spectroscopy (PCS). Dendrisome morphology and thermotropic properties were studied by transmission electron microscopy (TEM) and differential scanning calorimetry (DSC). Radiolabeled penicillin G was used as a model of a negatively charged water-soluble compound to investigate the encapsulation efficiency of the dendrisomes. In vitro release of the drug was determined using as a comparator a REV liposome formulation. Dendrisomes of all compositions have higher encapsulation efficiencies and slower release rates compared to the comparator. Cholesterol was found both to increase the size of the aggregates from around 310 to 560 nm and to increase shape irregularities, but did not change the positive zeta potential, in the order of +50 mV, of the dendrisomes. Cholesterol decreases penicillin G entrapment efficiency but increases solute leakage at 25degreesC. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:102 / 113
页数:12
相关论文
共 33 条
  • [1] Dendrisomes: cationic lipidic dendron vesicular assemblies
    Al-Jamal, KT
    Sakthivel, T
    Florence, AT
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) : 33 - 36
  • [2] [Anonymous], 1996, SCI SPECTRA
  • [3] Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives
    Beezer, AE
    King, ASH
    Martin, IK
    Mitchell, JC
    Twyman, LJ
    Wain, CF
    [J]. TETRAHEDRON, 2003, 59 (22) : 3873 - 3880
  • [4] Denkewalter R. G., 1981, [No title captured], Patent No. [4289872, US 4289872A]
  • [5] Dykes GM, 2001, CHEM-EUR J, V7, P4730, DOI 10.1002/1521-3765(20011105)7:21<4730::AID-CHEM4730>3.0.CO
  • [6] 2-A
  • [7] Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
    Esfand, R
    Tomalia, DA
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (08) : 427 - 436
  • [8] Interactions between a hydrophobically modified poly(amidoamine)dendrimer and surfactants in aqueous solutions
    Esumi, K
    Kuwabara, K
    Chiba, T
    Kobayashi, F
    Mizutani, H
    Torigoe, K
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2002, 197 (1-3) : 141 - 146
  • [9] The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
    Florence, AT
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 259 - 266
  • [10] Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
    Florence, AT
    Hussain, N
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 : S69 - S89